Log in to save to my catalogue

1801 Positive ANA testing in an academic medical center: impact on diagnosis

1801 Positive ANA testing in an academic medical center: impact on diagnosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ff57b29b5564dc6becdd5534b55a403

1801 Positive ANA testing in an academic medical center: impact on diagnosis

About this item

Full title

1801 Positive ANA testing in an academic medical center: impact on diagnosis

Publisher

London: Lupus Foundation of America

Journal title

Lupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A103-A103

Language

English

Formats

Publication information

Publisher

London: Lupus Foundation of America

More information

Scope and Contents

Contents

BackgroundAnti-nuclear antibodies (ANA) are common in systemic rheumatic diseases, non-rheumatic autoimmune diseases and the general population. In clinical practice, testing for ANA can inform further clinical diagnoses even in the absence of symptoms to suggest SLE or connective tissue disease. This study was undertaken to evaluate whether ANA te...

Alternative Titles

Full title

1801 Positive ANA testing in an academic medical center: impact on diagnosis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9ff57b29b5564dc6becdd5534b55a403

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9ff57b29b5564dc6becdd5534b55a403

Other Identifiers

E-ISSN

2053-8790

DOI

10.1136/lupus-2022-lupus21century.102

How to access this item